Inventiva IVA
NASDAQ IVA
$4.78 -0.06 (-1.24%)
As of: Sep 4, 2026 · 3:59 PM EDT

Inventiva (IVA) Total Liabilities (2018 - 2025)

Inventiva (IVA) posted quarterly Total Liabilities of $323.6 million for Q4 2025, up 34.24% year-over-year from $241.1 million in Q4 2024, and up 52.19% quarter-over-quarter from $212.7 million in Q2 2025.

Analysis

Inventiva (IVA) Total Liabilities (2018 - 2025) Analysis & Trends

Inventiva's Total Liabilities history runs 8 years deep, the most recent figure standing at $323.6 million for Q4 2025.

  • In Q4 2025, Total Liabilities rose 34.24% year-over-year to $323.6 million; the TTM figure through Dec 2025 stood at $323.6 million (up 34.24% YoY), while the FY2025 annual figure was $323.6 million, up 34.24% from the prior year.
  • Total Liabilities for Q4 2025 stood at $323.6 million, up from $212.7 million in the prior quarter.
  • The five-year high for Total Liabilities was $323.6 million in Q4 2025, with the low at $115662.5 in Q2 2022.
  • The 5-year median for Total Liabilities is $93.2 million (2023), against an average of $117.0 million.
  • The sharpest annual moves came in 2022 and 2023: Total Liabilities tumbled 99.92% in 2022, then jumped 66573.73% in 2023.
  • Inventiva's Total Liabilities stood at $37.9 million in 2021, then soared by 89.92% to $72.0 million in 2022, then surged by 51.91% to $109.3 million in 2023, then soared by 120.56% to $241.1 million in 2024, then soared by 34.24% to $323.6 million in 2025.
  • Business Quant data shows IVA's Total Liabilities at $323.6 million in Q4 2025, $212.7 million in Q2 2025, and $241.1 million in Q4 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.18 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 10.02 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.62 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 4.20 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 1.72 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 4.00 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 4.20 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 10.03 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.35 Bn
10 Inventiva 893.85 Mn 893.85 Mn - 323.64 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 323.64 Mn
Jun 30, 2025 212.65 Mn
Dec 31, 2024 241.09 Mn
Jun 30, 2024 118.46 Mn
Dec 31, 2023 109.31 Mn
Jun 30, 2023 78.57 Mn
Dec 31, 2022 71.96 Mn
Jun 30, 2022 35.00 Mn
Dec 31, 2021 37.89 Mn
Jun 30, 2021 26.14 Mn
Mar 31, 2021 27.04 Mn
Dec 31, 2020 24.06 Mn
Jun 30, 2020 22.62 Mn
Dec 31, 2019 10.62 Mn
Dec 31, 2018 20.79 Mn